Phylex BioSciences Designs AI Derived Andes Hantavirus Vaccine in Two Days
Phylex BioSciences has developed an AI derived mRNA nanoparticle vaccine candidate for the Andes hantavirus within two days of the virus sequence being posted by Geneva University Hospitals.